By
Drug Target Review2025-07-03T13:30:31
Scientists at the University of Sydney have discovered a malfunctioning brain protein linked to Parkinson’s - which could lead to new therapies for the debilitating condition in the future.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-04-12T15:28:08
Sponsored by nanoComposix
Site powered by Webvision Cloud